Expansion of cardiac ischemia/reperfusion injury after instillation of three forms of multi-walled carbon nanotubes

Table 3 Pulmonary Bronchoalveolar Lavage Fluid Protein (μg/ml)

Treatment	Dose	1 Day Post Aspiration	7 Day Post Aspiration	28 Day Post Aspiration
SS		0.07 ± 0.01	0.03 ± 0.01	0.15 ± 0.01
C-grade	1 μg	0.18 ± 0.01*	0.08 ± 0.01	0.12 ± 0.02
	100 μg	0.27 ± 0.04*†	0.12 ± 0.03	0.12 ± 0.01
COOH	1 μg	0.19 ± 0.02	0.07 ± 0.01	0.12 ± 0.01
	100 μg	0.30 ± 0.14	0.12 ± 0.03	0.12 ± 0.01
N-doped	1 μg	0.22 ± 0.02*	0.05 ± 0.01	0.17 ± 0.01
	100 μg	0.24 ± 0.04*	0.09 ± 0.01	0.19 ± 0.01

Bronchoalveolar lavage fluid (BALF) protein levels (μg/ml) following oropharyngeal aspiration of three forms of MWCNTs at 1μg and 100 μg or SS vehicle control (10% surfactant saline). The protein levels were performed on pooled aliquots of the BALF at 1 day, 7 day and 28 day post aspiration. Data reported as mean ± SEM for n = 4. * indicates significance from SS, † indicates significance from 1 μg dose within the same MWCNT form, P ≤ 0.05.

ISSN: 1743-8977